01—History
Net Income History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $4.50B
1 older move runs past ±150% (largest +438.3%); point at, tap or drag across the bars to read one.
02—Ledger
Net Income, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $4.50B | +2.1% | 10-K | |
| FY2024 | $4.41B | +11.6% | 10-K | |
| FY2023 | $3.95B | −8.9% | 10-K | |
| FY2022 | $4.34B | −46.3% | 10-K | |
| FY2021 | $8.08B | +129.9% | 10-K | |
| FY2020 | $3.51B | +66.0% | 10-K | |
| FY2019 | $2.12B | −13.4% | 10-K | |
| FY2018 | $2.44B | +104.0% | 10-K | |
| FY2017 | $1.20B | +33.8% | 10-K | |
| FY2016 | $895.5M | +40.8% | 10-K | |
| FY2015 | $636.1M | +88.1% | 10-K | |
| FY2014 | $338.1M | −18.3% | 10-K | |
| FY2013 | $413.7M | −44.9% | 10-K | |
| FY2012 | $750.3M | +438.3% | 10-K | |
| FY2011 | −$221.8M | −112.3% | 10-K | |
| FY2010 | −$104.5M | −54.0% | 10-K | |
| FY2009 | −$67.8M | +14.3% | 10-K | |
| FY2008 | −$79.1M | — | 10-K |
03—Questions
What is net income?
Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.
What is Regeneron Pharmaceuticals's current net income?
Regeneron Pharmaceuticals (REGN) annual net income for 2025 was $4.50B, a 2.09% increase from 2024. Regeneron Pharmaceuticals net income for the quarter ending September 30, 2026 was $1.95B.
What was Regeneron Pharmaceuticals's net income in 2024?
Regeneron Pharmaceuticals annual net income for 2024 was $4.41B, a 11.61% increase from 2023.
What was Regeneron Pharmaceuticals's net income in 2023?
Regeneron Pharmaceuticals annual net income for 2023 was $3.95B, a 8.87% decline from 2022.
What is Regeneron Pharmaceuticals's 5-year net income CAGR?
Regeneron Pharmaceuticals net income grew at a compound annual growth rate (CAGR) of 5.10% from FY2020 to FY2025, going from $3.51B to $4.50B over 5 years.
- Company
- Regeneron Pharmaceuticals
- Ticker
- REGN
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations